US EditionPulnovo’s PADN Catheter Receives CE Mark Clearance Under EU MDR - Cardiac Interventions Today
Summary by Cardiac Interventions Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Pulnovo’s PADN Catheter Receives CE Mark Clearance Under EU MDR - Cardiac Interventions Today
April 16, 2025—Pulnovo Medical, a China-based developer of medical devices for pulmonary hypertension (PH) and heart failure, announced that its pulmonary artery denervation (PADN) catheter for treating PH has received CE Mark clearance under the European Union Medical Device Regulation. According to Pulnovo, the PADN catheter targets overactive sympathetic nerve activity to lower pulmonary artery pressure in patients with PH. Its clinical benef…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
